Ass’n for Molecular Pathology v. USPTO, No. 2010-1406 (the Myriad Genetics case)

Fitzpatrick Case Update
July 29, 2011

The Federal Circuit today issued a key biotechnology opinion, holding that isolated human DNA sequences are patentable subject matter under 35 U.S.C. § 101. Fitzpatrick attorneys Robert Fischer and Dennis Gregory examine this opinion.

View Attachment (PDF)